R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

pharmaphorum podcast Episode 174a - Tomasz Kostrzewski, CN Bio

Driving the drug discovery pipeline: The value of organ-on-a...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tomasz Kostrzewski, CSO at CN Bio, about single organ-on-a-chip technology.

R&D

Bridging the lab gap: Expanding access to cutting-edge resea...

The global demand for state-of-the-art research facilities is limited by the current supply, leaving many regions unable to support innovation outside of established hubs like Boston, San D

R&D

pharmaphorum podcast Episode 173a - Sonia A. Veluchamy, Celegence

Intelligent regulatory compliance and improved patient outco...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Sonia A. Veluchamy, CEO and co-founder of Celegence.

R&D

Supercharging clinical development with RWE – with Recursion...

Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.

R&D

Yellow origami boat sailing a different path than a line of white origami boats

Webinar recap: The future of cell and gene therapy in rare d...

For decades, treatment options for rare diseases have been limited, often focusing on symptom management rather than addressing the root cause of them

R&D

Obesity and the endoscopy space: Innovative, minimally invas...

According to the World Health Organization (WHO), in 2022, 2.5 billion adults aged 18 years and older were overweight, including over 890 million adults who were living with